Similar articles

• Platelet-activating factor and arachidonic acid metabolites mediate tumor necrosis factor and eicosanoid kinetics and cardiopulmonary dysfunction during bacteremic shock.

  Quinn JV, Slotman GJ. Quinn JV, et al. Crit Care Med. 1999 Nov;27(11):2485-94. doi: 10.1097/00003246-199911000-00027. Crit Care Med. 1999. PMID: 10579269
• Sequential release of tumour necrosis factor, platelet activating factor and eicosanoids during endotoxin shock in anaesthetized pigs: protective effects of indomethacin.

  Mózes T, Zijlstra FJ, Heiligers JP, Tak CJ, Ben-Efraim S, Bonta IL, Saxena PR. Mózes T, et al. Br J Pharmacol. 1991 Nov;104(3):691-9. doi: 10.1111/j.1476-5381.1991.tb12490.x. Br J Pharmacol. 1991. PMID: 1797328 Free PMC article.
• Role of eicosanoids in regulation of macrophage phagocytic functions by platelet-activating factor during endotoxic shock.

  Zaitseva L, Vaisburd M, Shaposhnikova G, Mysyakin E. Zaitseva L, et al. Bull Exp Biol Med. 2000 Sep;130(9):879-81. doi: 10.1007/BF02682259. Bull Exp Biol Med. 2000. PMID: 11177271
• [The role of arachidonic acid metabolites in the mechanism of endotoxic shock and the current principles of pathogenetic therapy].

  Kharlanova NG, Lomov IuM, Bardakhch'ian EA. Kharlanova NG, et al. Lik Sprava. 1993 Sep;(9):32-7. Lik Sprava. 1993. PMID: 8085344 Review. Russian. No abstract available.
• Therapeutic options directed against platelet activating factor, eicosanoids and bradykinin in sepsis.

  Fink MP. Fink MP. J Antimicrob Chemother. 1998 Jan;41 Suppl A:81-94. doi: 10.1093/jac/41.suppl_1.81. J Antimicrob Chemother. 1998. PMID: 9511090 Review.